anti CD68 antibody, anti CD68gen antibody, anti CD68 molecule antibody, anti DKFZp686M18236 antibody, anti GP110 antibody, anti Macrophagegen CD68 (microsialin) antibody, anti macrosialin antibody, anti SCARD1 antibody, anti Scavenger receptor class D member 1 antibody
CD68 antibody
Clonality:
Polyclonal
Concentration:
- 100 µg (in 200 µl): 0.5 mg/ml- 200 µg (in 400 µl): 0.5 mg/ml
Polyclonal antibodies are purified by peptide affinity chromatography
Form:
10 mM PBS, 0.02% sodium azide
Target:
CD68
Application Dilute:
WB: 2 µg/ml, IHC-P:1:100, IF/ICC: 1:100
Application Notes:
Application Notes: Representative images showing the presence of macrophages in the ovary. Macrophages were identified using marker CD68. Increased expression of macrophage marker CD68 was noted in both the HF-Ln (n6) and HF-Ob (n6) groups compared to the LF-Ln mice (n6), both after 10 (A) and 32 (B) weeks on HFD. These findings indicate increased tissue inflammation in the ovary after prolonged exposure to HFD regardless of obese phenotype. Ctrl, control. Original magnification 3200
Immunofluorescence analysis of mouse lymph node tissue using CD68 antibody (dilution of primary antibody - 1:100)
IHC-P staining of rat spleen tissue using anti-CD68 (dilution at 1:100)
Representative images showing the presence of macrophages in the ovary. Macrophages were identified using marker CD68. Increased expression of macrophage marker CD68 was noted in both the HF-Ln (n6) and HF-Ob (n6) groups compared to the LF-Ln mice (n6)
Representative images showing the presence of macrophages in the ovary. Macrophages were identified using marker CD68. Increased expression of macrophage marker CD68 was noted in both the HF-Ln (n6) and HF-Ob (n6) groups compared to the LF-Ln mice (n6)
IHC-P image of mouse lymph node tissue using anti-CD68 (dilution of primary antibody at 1:100)
Immunohistochemical staining of rat spleen tissue using CD68 antibody (dilution of primary antibody - 1:100)
Western blot analysis of breast cancer (Lane 1), breast cancer (Lane 2), breast cancer (Lane 3) using CD68 antibody (dilution at 2 ug/ml)
* VAT and and shipping costs not included. Errors and price changes excepted
